Unique ID issued by UMIN | UMIN000024947 |
---|---|
Receipt number | R000028705 |
Scientific Title | A confirmation study of anti-obesity effect by test food intake. |
Date of disclosure of the study information | 2016/11/22 |
Last modified on | 2020/10/05 18:07:35 |
A confirmation study of anti-obesity effect by test food intake.
Confirmation of anti-obesity effect of the test food.
A confirmation study of anti-obesity effect by test food intake.
Confirmation of anti-obesity effect of the test food.
Japan |
Adults in good health
Not applicable | Adult |
Others
NO
To confirm anti-obesity effect of test food intake.
Efficacy
Body weight, body mass index and body fat percentage.
Intestinal microflora and blood lipid level.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Ingesting the jelly which contains test food, 3 sticks in a day, for 8 weeks.
Ingesting the jelly which does not contain test food, 3 sticks in a day, for 8 weeks.
20 | years-old | <= |
65 | years-old | > |
Male and Female
1) Males and females aged 20 to 64 years old when obtaining informed consent.
2) Subjects whose body mass index (BMI) is and over 25.0kg/m2.
3) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.
1) Subjects who are given continuous treatment by taking medicines.
2) Subjects who constantly use oral medicines, functional foods and/or supplements having a possibility of affecting test results.
3) Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney and/or digestive trucks.
4) Pregnant or possibly pregnant females, or lactating females.
5) Subjects who excessive alcohol intake.
6) Subjects who have extremely irregular life rhythms, and subjects who have midnight work or irregular shift work.
7) Subjects who have previous medical history of drug and/or food allergy.
8) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within 4-weeks prior to the current study.
9) Subjects who donated over 200mL blood and/or blood components within a month to the current study.
10) Males who donated over 400mL blood within the last three months to the current study.
11) Females who donated over 400mL blood within the last four months to the current study.
12) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study.
13) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study.
14) Others who have been determined ineligible by principal investigator or sub-investigator.
24
1st name | Katsuhisa |
Middle name | |
Last name | Sakano |
CPCC Company Limited
Clinical Research Planning Department
101-0047
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
1st name | Masanori |
Middle name | |
Last name | Numa |
CPCC Company Limited
Sales and Planning Department
101-0047
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Cooperative Association LATEST
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-5548
IRB@cpcc.co.jp
NO
チヨダパラメディカルケアクリニック、(東京都)
2016 | Year | 11 | Month | 22 | Day |
Unpublished
Completed
2016 | Year | 11 | Month | 17 | Day |
2016 | Year | 11 | Month | 22 | Day |
2016 | Year | 11 | Month | 22 | Day |
2020 | Year | 10 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028705